申请人:Astrazeneca AB
公开号:US06492406B1
公开(公告)日:2002-12-10
The present invention relates to novel compounds which are protein kinase C inhibitors, methods for their preparation, intermediates therefor and pharmaceutical compositions comprising them. More particularly, the present invention relates to compounds of formula (I):
wherein: one of Ar1 and Ar2 is optionally substituted bicyclic heteroaryl or optionally substituted tricyclic heteroaryl and the other is optionally substituted heteroaryl or optionally substituted aryl;
X is O or S; and
R is H, OH, NH2 or C1-6 alkyl (itself optionally substituted by amino or hydroxy); or a salt or solvate thereof, or a solvate of a salt thereof; and the use of such compounds in medical therapies.
本发明涉及一种新型化合物,它们是蛋白激酶C抑制剂,以及用于它们的制备方法,中间体和包括它们的药物组合物。更具体地说,本发明涉及具有以下结构的化合物(I):其中:Ar1和Ar2中的一个是可选择取代的双环杂芳基或可选择取代的三环杂芳基,另一个是可选择取代的杂芳基或可选择取代的芳基;X为O或S;R为H、OH、NH2或C1-6烷基(本身可选择通过氨基或羟基取代);或其盐或溶剂化物,或其盐的溶剂化物;以及这类化合物在医学治疗中的用途。